OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Sequential delivery of PD-1/PD-L1 blockade peptide and IDO inhibitor for immunosuppressive microenvironment remodeling via an MMP-2 responsive dual-targeting liposome
Chuan Hu, Yujun Song, Yiwei Zhang, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 5, pp. 2176-2187
Open Access | Times Cited: 38
Chuan Hu, Yujun Song, Yiwei Zhang, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 5, pp. 2176-2187
Open Access | Times Cited: 38
Showing 26-50 of 38 citing articles:
Supramolecular artificial Nano-AUTACs enable tumor-specific metabolism protein degradation for synergistic immunotherapy
Yazhen Wang, Lianyi Yang, C. Yan, et al.
Science Advances (2024) Vol. 10, Iss. 25
Open Access | Times Cited: 3
Yazhen Wang, Lianyi Yang, C. Yan, et al.
Science Advances (2024) Vol. 10, Iss. 25
Open Access | Times Cited: 3
Functionalized liposomes: an enticing nanocarrier for management of glioma
Vasu Peddinti, Biswajit Rout, Tejas Girish Agnihotri, et al.
Journal of Liposome Research (2023) Vol. 34, Iss. 2, pp. 349-367
Closed Access | Times Cited: 8
Vasu Peddinti, Biswajit Rout, Tejas Girish Agnihotri, et al.
Journal of Liposome Research (2023) Vol. 34, Iss. 2, pp. 349-367
Closed Access | Times Cited: 8
Development of LAG-3/FGL1 blocking peptide and combination with radiotherapy for cancer immunotherapy
Yuzhen Qian, Yixuan Sun, Peishang Shi, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 14, Iss. 3, pp. 1150-1165
Open Access | Times Cited: 8
Yuzhen Qian, Yixuan Sun, Peishang Shi, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 14, Iss. 3, pp. 1150-1165
Open Access | Times Cited: 8
Exploring the Potential of Nanoparticles in the Treatment of Breast Cancer: Current Applications and Future Directions
Puja Patel, Vadanasundari Vedarethinam, Maame A. Korsah, et al.
Applied Sciences (2024) Vol. 14, Iss. 5, pp. 1809-1809
Open Access | Times Cited: 2
Puja Patel, Vadanasundari Vedarethinam, Maame A. Korsah, et al.
Applied Sciences (2024) Vol. 14, Iss. 5, pp. 1809-1809
Open Access | Times Cited: 2
GSH-responsive polymeric micelles-based augmented photoimmunotherapy synergized with PD-1 blockade for eliciting robust antitumor immunity against colon tumor
Chenlu Huang, Xinyu Yang, Huidong Li, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
Chenlu Huang, Xinyu Yang, Huidong Li, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
Miriplatin-loaded liposome, as a novel mitophagy inducer, suppresses pancreatic cancer proliferation through blocking POLG and TFAM-mediated mtDNA replication
Xiaowei Wang, Mengyan Wang, Meilian Cai, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 11, pp. 4477-4501
Open Access | Times Cited: 5
Xiaowei Wang, Mengyan Wang, Meilian Cai, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 11, pp. 4477-4501
Open Access | Times Cited: 5
The cross-talk between macrophages and tumor cells as a target for cancer treatment
Muhammad Aizaz, Aakif Ullah Khan, Faisal Khan, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 4
Muhammad Aizaz, Aakif Ullah Khan, Faisal Khan, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 4
Endoplasmic reticulum-targeted biomimetic nanoparticles induce apoptosis and ferroptosis by regulating endoplasmic reticulum function in colon cancer
Hongxin Tan, Ziqi Shen, Xiao Hua Wang, et al.
Journal of Controlled Release (2024) Vol. 375, pp. 422-437
Closed Access | Times Cited: 1
Hongxin Tan, Ziqi Shen, Xiao Hua Wang, et al.
Journal of Controlled Release (2024) Vol. 375, pp. 422-437
Closed Access | Times Cited: 1
Biomimic Nanodrugs Overcome Tumor Immunosuppressive Microenvironment to Enhance Cuproptosis/ChemodynamicâInduced Cancer Immunotherapy
Hangyi Wu, Xiaoyu Lu, Yuhan Hu, et al.
Advanced Science (2024)
Open Access | Times Cited: 1
Hangyi Wu, Xiaoyu Lu, Yuhan Hu, et al.
Advanced Science (2024)
Open Access | Times Cited: 1
Luminescence-activated Pt(IV) prodrug for in situ triggerable cancer therapy
Huijie An, Chen Yang, Zhihui Jiang, et al.
Chinese Chemical Letters (2023) Vol. 35, Iss. 7, pp. 109134-109134
Closed Access | Times Cited: 2
Huijie An, Chen Yang, Zhihui Jiang, et al.
Chinese Chemical Letters (2023) Vol. 35, Iss. 7, pp. 109134-109134
Closed Access | Times Cited: 2
Nano-medicine therapy reprogramming metabolic network of tumour microenvironment: new opportunity for cancer therapies
Xiaojie Zhang, Min An, Juntao Zhang, et al.
Journal of drug targeting (2024) Vol. 32, Iss. 3, pp. 241-257
Closed Access
Xiaojie Zhang, Min An, Juntao Zhang, et al.
Journal of drug targeting (2024) Vol. 32, Iss. 3, pp. 241-257
Closed Access
Breast Cancer Treatment: The Potential of Organic and Inorganic Nanocarriers in Targeted Drug Delivery
Saravanan Alamelu, Kamalesh Balakumar Venkatesan, Kalist Shagirtha, et al.
Drugs and Drug Candidates (2024) Vol. 3, Iss. 4, pp. 813-837
Open Access
Saravanan Alamelu, Kamalesh Balakumar Venkatesan, Kalist Shagirtha, et al.
Drugs and Drug Candidates (2024) Vol. 3, Iss. 4, pp. 813-837
Open Access
Advances in tumor stroma-based targeted delivery
Chunyan Wu, Yujia Zhai, Jianbo Ji, et al.
International Journal of Pharmaceutics (2024) Vol. 664, pp. 124580-124580
Closed Access
Chunyan Wu, Yujia Zhai, Jianbo Ji, et al.
International Journal of Pharmaceutics (2024) Vol. 664, pp. 124580-124580
Closed Access
Targeted Chemoimmunotherapy for Hepatocellular Carcinoma: Dual-Stimulus Responsive Nanocarrier for Enhanced Antitumor Response
Jinxiao Song, Zhenghui Jing, Jingyi Zhou, et al.
Research Square (Research Square) (2023)
Open Access
Jinxiao Song, Zhenghui Jing, Jingyi Zhou, et al.
Research Square (Research Square) (2023)
Open Access
